MKI67 and neoplasm: Immunochemistry staining and western blot analyses confirmed that the expression of MED1 was significantly depleted in the pRNA-HER2apt-siMED1-treated groups along with a great reduction of Ki-67 expression, tumor growth, lung metastasis and stem cell formation compared to those of control treatments.